For the eighth time, the international Formnext Start-up Challenge has recognized young companies from the world of additive manufacturing for their innovative business ideas and technical developments. The award-winning innovations are shining examples of the high innovative power of 3D printing and the AM market.
The Formnext Start-up Challenge 2022 recognizes inventive, viable business ideas from companies founded within the last five years.
(Source: Mesago / Mathias Kutt)
From the on-demand production of AM powders through degradable implants and efficient robotic post-processing: The international winners of the Formnext Start-up Challenge will all present their innovations to the AM world at Formnext 2022. The winners are Photosynthetic (Netherlands), Lattice Medical (France), Rivelin Robotics (UK), Spherecube (Italy) and Alpha Powders (Poland). The AM Ventures Impact Award also went to Lattice Medical.
The innovations of these start-ups were selected both for the high level of creativity demonstrated in product development as well as the viability of the business models. The start-ups were able to provide proof of existing patents or patents pending and also demonstrated extremely promising applications.
Warsaw-based start-up Alpha Powders has developed and patented a technology for the on-demand modification of polymer powders. Similarly working with minute dimensions is Dutch start-up Photosynthetic, which specializes in fast and cost-effective micro 3D printing. British start-up Rivelin Robotics, on the other hand, has its sights set on improving efficiency in the additive process chain. Its Netshape robots offer the potential of reducing operating costs and errors in post-processing by a factor of ten. For Italian start-up Spherecube, greater stability is the focus. The company has developed 3D printing technology that is able to process continuous fiber composites, thus enabling the automated manufacture of products from high-performance composites in any desired shape. Biomedical start-up Lattice Medical has developed a disruptive, bioabsorbable, and personalized implant for breast reconstruction and breast augmentation using patented 3D technology, which encourages the natural regeneration of adipose tissue without the introduction of foreign bodies.
With its submission, Lattice Medical was also able to secure the AM Ventures Impact Award, which honors particularly sustainable approaches. In addition to the innovative design and production method, AM Ventures was particularly impressed by the minimization of risks that can occur with traditional implants, the technical expertise of the team, and the sound research results that support the application.
Sascha F. Wenzler, Vice President of Formnext at organizer Mesago Messe Frankfurt: “Every year, the start-ups in the AM industry take technology and application innovations to the next level and continue to impress with the rising quality of their developments and business planning. Once again, these companies have showcased the great potential of this industry, highlighting the fact that the sector produces significant developments that, in the future, will influence our industry, medicine, and other areas of life.”
The Formnext Start-up Challenge 2022 recognizes inventive, viable business ideas from companies founded within the last five years. The distinguished judging panel consists of prominent representatives from the realms of industry, science, media, and investment. The winners will each have a dedicated exhibition booth and will also present themselves at the Formnext Pitchnext event on Tuesday 15 November 2022.
Warsaw-based start-up Alpha Powders (booth 12.0-B81G) has developed and patented a technology for the pulverization, spheroidization and on-demand modification of polymer powders. The company’s current focus is the development of a compact device specifically for R&D laboratories working on new SLS powders. The prototype has been tested with a variety of materials, including polyamides, TPU, or polyolefin powders, and has been proven to reliably produce spherical SLS powders by dry process. The company continues to develop this technology and aims to offer pilot and production scale solutions in the coming years.
3D-printed bioabsorbable implants to improve healing
Lattice Medical (booth 12.0-B81B) is a biomedical start-up that was founded in October 2017. The French company has developed a patented 3D technology in cooperation with CHU Lille-France that enables the natural regeneration of adipose tissue, bringing enormous improvements in breast implant procedures, for example. The Mat(t)isse bioprosthesis is made of 3D-printed biomaterials, is fully bioabsorbable, and is adapted to the individual morphology of the patient. Breasts are thus entirely reconstructed from the patient’s own tissue, and no foreign bodies are introduced.
Fast micro 3D printing
Photosynthetic (booth 12.0-B81H) specializes in fast and cost-effective micro 3D printing. 3D microstructures are generally fabricated using conventional methods such as two-photon lithography (TPL), stereolithography (SLA), and optical grayscale lithography (OGL). The Dutch start-up’s patented technology, on the other hand, uses an optical hardware system, resins based on single-photon polymerization, and computer algorithms to control the printing process. Photosynthetic’s new micro 3D printer enables fast microfabrication (50 mm3/hour) in high-resolution mode (<1 micron).
Significant cost savings in post-processing
With its Netshape robots, British start-up Rivelin Robotics (booth 12.0-B41) has developed a solution for the rapid post-processing of additively manufactured metal parts and components. In many metal AM applications, post-processing contributes upwards of 30 percent of unit cost per part. For support removal and targeted finishing, Rivelin has developed Netshape Robots, driven by the powerful Netshape control software which uses both machine learning and traditional deterministic control theory. The result is an automated support removal solution that reduces defects by 90 percent, results in a 10-fold reduction in operational costs, and eliminates human risk and variability.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
Improved AM composite bonding
Italian start-up Spherecube (booth 12.0-B81A) has developed 3D printing technology that is able to process polymer-based composite materials or a thermosetting matrix with continuous fiber reinforcement, thus enabling the automated manufacture of products from high-performance composites in any desired shape. According to the company, its technology differs from the processes currently available by curing the plastic under heat, which improves wetting and bonding of the fiber reinforcements, matrix, and the 3D-printed layers.